Weed in Review: Friday, January 19, 2018
In the United States
GOP And Democratic Gubernatorial Candidates Agree: Legalize Marijuana: On Monday, New York Republican gubernatorial hopeful Joel Giambra unveiled a proposal to legalize marijuana and use the resulting tax revenue to fund subway repairs and other transportation projects. “I think that legalizing marijuana and using the revenues to create an infrastructure fund to deal with these problems is a much more appropriate way to solve our problems than raising new taxes,” he said.
Report Supports Help for Minorities in Medical Cannabis Industry: Data on discrimination in Maryland’s overall economy provides “a strong basis in evidence” to support helping businesses owned by women and minorities in the types of industries relevant to the state’s fledgling medical marijuana industry, a state report released Wednesday said.
GOP Senator Offers Bill to Legalize Cannabis in Kentucky: Eight states and the District of Columbia have legalized marijuana for recreational use. Taxing the production, processing and use of marijuana could generate between $100 million and $200 million yearly — revenue that Kentucky badly needs, Seum said.
What a Cannabis Fact Sheet looks like in the UK: Cannabidiol (CBD) and its control status: CBD as an isolated substance, in its pure form, would not be controlled under the MDA 1971 / MDR 2001. If a CBD ‘product’ contained any controlled cannabinoids, unintentionally or otherwise (e.g., THC or CBD-V), then it is highly likely that the product would be controlled. It is our understanding that it is very difficult to isolate pure CBD, and in our experience many products in fact do not fully disclose their contents or provide a full spectrum analysis at an appropriate level of sensitivity to accurately and consistently determine their true content or control status. THC-A and its control status: THC-A as an isolated substance, in its pure form, would not be controlled under the MDA 1971 / MDR 2001. However, it is understood that THC-A readily degrades both naturally, and with a catalyst or environmental change (e.g. ingestion) to THC which is a Schedule 1 controlled cannabinoid.
Medical marijuana, Inc. subsidiary HEMPMEDS® Wins product registration hearing in Puerto Rico, beings selling RSHO™ as first-ever approved nutraceutical product: “We are pleased with the decision to reinstate the registration of HempMeds products in Puerto Rico, as we can now continue providing the more than 3.6 million residents of this territory with CBD hemp oil products that are helping people around the world,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We are extremely proud to have been the first Company to provide the people of Puerto Rico with CBD hemp oil products, especially after the World Health Organization’s recent recommendation not to schedule CBD.”
Study: Marijuana Regulation Reduces Organized Crime Activity: Bergen, Norway: The regulation of marijuana for medical purposes is associated in a decrease in violent crimes committed by Mexican drug trafficking organizations, according to data published in The Economic Journal.